Niacinamide

Niacinamide

SCHEMBL5712652

CN.NC(=O)c1cccnc1

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F7 P08709 1/20 0.92
▸ F3 P13726 1/20 0.92
▸ SARM1 Q6SZW1 1/20 0.92
▸ SIRT2 Q8IXJ6 1/20 0.92
▸ SIRT6 Q8N6T7 1/20 0.92
▸ SIRT1 Q96EB6 1/20 0.92
▸ SIRT3 Q9NTG7 1/20 0.92
▸ SIRT5 Q9NXA8 1/20 0.92
▸ SIRT4 Q9Y6E7 1/20 0.92
▸ ALDH1A1 P00352 2/20 0.61
▸ APP P05067 1/20 0.61
▸ GAA P10253 1/20 0.61
▸ HCAR3 P49019 1/20 0.61
▸ HCAR2 Q8TDS4 1/20 0.61
▸ MKNK1 Q9BUB5 3/20 0.59
▸ MKNK2 Q9HBH9 3/20 0.59
▸ HDAC1 Q13547 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.55
▸ POLB P06746 2/20 0.52
▸ PLOD2 O00469 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niacinamide SCHEMBL27671762 0.96 F7 (0.92) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL29624874 0.96 — —
Niacinamide SCHEMBL19978192 0.96 — —
Niacinamide SCHEMBL2926 0.96 — —
Niacinamide SCHEMBL460466 0.96 F7 (1.00) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL28744959 0.94 F7 (0.88) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL20298468 0.94 F7 (0.88) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL4101623 0.94 F7 (0.88) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL25366418 0.94 — —
Niacinamide SCHEMBL1063189 0.94 F7 (0.96) F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613597-A1 6-SUBSTITUTED NICOTINAMIDE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2006-01-11 — — EP disclosed
WO-2004080968-A1 6-SUBSTITUTED NICOTINAMIDE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2004-09-23 — — WO disclosed
Send feedback